DNA

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

CHATHAM, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated…

1 year ago

Rakovina Therapeutics to Present Research Highlighting Small-Molecule Bifunctional Inhibitors of PARP1/2 and HDAC Enzymes at the 36th EORTC-NCI-AACR Symposium in Barcelona Spain

VANCOUVER, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical…

1 year ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that…

1 year ago

Ayana Bio to Showcase Plant Cell Advantage™ Health & Wellness Ingredients at SupplySide West 2024

Ayana Bio's NeuroAdvantage and ImmunAdvantage prototypes will be available at SupplySide West booth #7071. BOSTON, Oct. 24, 2024 /PRNewswire/ --…

1 year ago

Leading HIM & Coding Vendors Driving Breakthrough Innovation, Setting the Pace for Industry Transformation, Reports Black Book Survey

Top medical coding and HIM solutions, recognized by clients and system users among the best in the industry, will showcase…

1 year ago

BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat)

Additional real-world studies show sustained HAE attack rate reduction after initiating ORLADEYO, regardless of C1-INH status, and patient preference for…

1 year ago

Triple Board-Certified Surgeon and Hair Transplant Expert Dr. Jason Dudas Joins the Aesthetic Surgery Center in Naples, FL

Leading hair transplant surgeon Dr. Jason Dudas brings cutting-edge techniques to Naples.NAPLES, FL / ACCESSWIRE / October 23, 2024 /…

1 year ago

Access Genetics Acquires Breakthrough Point-of-Care Rapid PCR Technology

Patent-pending real-time quantitative PCR testing platform was acquired by Access Genetics from Sensible Diagnostics. EDEN PRAIRIE, Minn., Oct. 22, 2024…

1 year ago

Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery

The first in a series of Dotmatics Luma Multimodal R&D Solutions Geneious has been seamlessly composed into Luma showcasing cross-therapeutic…

1 year ago

Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184

Company to conduct a Phase 1 Drug-Drug Interaction StudyPhase 2 filing on track for Q1 2025 SOUTH SAN FRANCISCO, Calif.,…

1 year ago